TNF Pharmaceuticals (TNFA), announced that it has initiated the first in a series of studies to evaluate the impact of its novel oral TNF-alpha ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

Financial writer highlights V.F. Corporation's Q3 '25 earnings, cautioning on valuation and recommending a wait for a lower ...

V.F. Corp.'s Q3 fiscal 2025 earnings exceeded expectations, yet shares fell 4% after initial euphoria. Read why I remain neutral on VFC stock.

In a challenging market environment, TNFA stock has reached a 52-week low, dipping to $1.02. With a high beta of 2.48, the stock shows significant volatility compared to the broader market. This ...

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

55 11 3061 7457 Fax: +55 11 3081 7190 [email protected] Establishing that TNF-α plays an important role in the pathogenesis of several immune-mediated inflammatory diseases led to the development of ...

BRIDGEWATER, NJ / ACCESS Newswire / January 27, 2025 / , Inc. (Nasdaq:THAR) ("" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and ...

SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long term, according to a study from the UK and Ireland.

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

在充满挑战的市场环境中，TNFA股票已触及52周新低，跌至1.02美元。该股票的贝塔系数高达2.48，显示出相对于大盘明显的波动性。这一显著下跌反映了更广泛的市场趋势和公司内部struggles，引发了投资者的担忧。根据 InvestingPro 分析，该股票在当前水平似乎被低估。过去一年，TNFA的价值大幅下降，一年变化率显示steep ...

The conference, entitled “Healthcare Beyond Borders,” included talks from two keynote speakers, panel sessions, and a career ...